NCT07673029 — HER2-positive Breast Cancer trial site landscape

Public-registry site landscape for NCT07673029, a HER2-positive Breast Cancer study sponsored by GeneQuantum Healthcare (Suzhou) Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07673029 (registry record)
Sponsor	GeneQuantum Healthcare (Suzhou) Co., Ltd.
Condition(s)	HER2-positive Breast Cancer
Phase	PHASE3
Listed sites	70
Site countries	China

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07673029 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.